Outcomes from treating orthopedic infection with debridement and implanted antibiotic were similar whether followed by short or standard duration of systemic antibiotic.
|Articles|October 20, 2022
A 4-Year Antimicrobial Stewardship Program Successfully Reduces Antibiotic Resistance
Author(s)Nina Cosdon
Antimicrobial stewardship works, one IDWeek 2022 study found.
Advertisement
Antimicrobial resistance (AMR) poses a significant and growing threat to public health. The main driver of these pathogens becoming increasingly difficult to treat is an over-prescription of
The investigators monitored pharmacy data from 2015 (pre-ASP intervention), and from 2016-2019 (post-intervention). They examined the antibiotic consumption and resistance rates of a 427-bed tertiary general hospital. Utilizing the clinical microbiology laboratory’s electronic database, the investigators obtained AMR data.
To achieve a successful ASP, the investigators employed a pre-authorization intervention strategy for protected antibiotics, including tigecycline, carbapenems, quinolones, glycopeptides, daptomycin, colistin, and linezolid. They deescalated or switched from intravenous to oral administration, appropriately selecting the duration of chemoprophylaxis in surgery.
After 4 years of the ASP, the investigators noted significant reductions in total antibiotics, total antibiotics, colistin, carbapenems, quinolones, and tigecycline consumption. They recorded far lower resistance rates in 2019 than in 2015 for Pseudomonas aeruginosa and Klebsiella pneumoniae.
There were no significant changes in the resistant rates of Acinetobacter baumannii isolates, which remained highly resistant to more than 90% of carbapenems in the hospital. However, infections caused by Gram-positive pathogens were reduced.
Lower rates of vancomycin-resistant enterococci were noted after the implementation of the ASP; for E faecium, rates reduced from 50.0% in 2015 to 30.4% in 2019, and from 6% to 0.6% for E faecalis. Methicillin-resistant S aureus isolates had increased antimicrobial resistance, 40% in 2019 versus 31.1% in 2015, which the investigators hypothesized could be because most of these pathogens are not
The study authors concluded that the antimicrobial stewardship program successfully reduced antibiotic consumption at their hospital, and reduced antimicrobial resistance in dangerous pathogens.
This study, “Impact of A Four-Year Antimicrobial Stewardship Program on Antimicrobial Resistance,” was presented by Georgios Chrysos at IDWeek 2022, held October 19-23, 2022, in Washington, D.C.
Advertisement
Related to this article
In this week's top infectious disease stories, a Pennsylvania teen became the state's fourth measles death in weeks, the CDC reported a 17% summer surge in rabies exposure calls, new research revisited whether cefepime raises mortality risk, a multihospital review examined ceftriaxone's safety after state alerts, and examining Legionella pneumonia diagnostics.
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
New gyrA testing guides ciprofloxacin use for gonorrhea, cutting ceftriaxone reliance while tackling resistance, access, and FDA hurdles.
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Resistance-guided testing targeting a single gene mutation could let clinicians safely reintroduce ciprofloxacin for the majority of gonorrhea cases still susceptible to it, sparing ceftriaxone as resistance climbs worldwide. Lao-Tzu Allan-Blitz, MD, MPH, offers insights into his work in this area.
Adding bismuth to amoxicillin-vonoprazan increased efficacy of the combination for H pylori, and exceeded that of clarithromycin-based triple therapy without contributing to clarithromycin resistance.
Editor in chief Jason Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS, discusses the proposed OMB rule restricting federal grants for international research collaboration, and how it threatens infectious disease medicine's inherently borderless surveillance networks, publication access, and knowledge-sharing systems.
Advertisement
Advertisement
Trending on Contagion Live
1
Asymptomatic C difficile Colonization in Infants Doesn’t Mean Benign
2
How The Food Safety Surveillance Infrastructure Works in the US
3
Implanted Antibiotic Reduced Systemic Regimen for Orthopedic Infection
4
Evaluating Ebola Vaccine Against Current Bundibugyo Species
5